ArticleScientific reports2025
Influence of infant fucosyltransferase polymorphisms on the association of maternal secretor status with child outcomes: the Ulm birth cohort studies.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The influence of maternal secretor status and child fucosyltransferase (FUT2) polymorphisms on respiratory and ear infections, and growth, is an emerging research area. But, the impact of discordant secretor status between mother and infant, where their secretor status differs, remains underexplored. This study investigated how infant FUT2 single nucleotide polymorphisms (SNPs) modify the association between maternal secretor/non-secretor milk phenotypes and child outcomes such as infections, and growth during the first two years of life in discordant mother-infant pairs. Data from n = 539 mother-infant pairs in the Ulm SPATZ Health Study (SPATZ) and n = 488 pairs in the Ulm Birth Cohort Study (UBCS) were analysed using logistic, modified Poisson, and linear regression models. A significant proportion of infants in both cohorts were heterozygous secretors (46% in SPATZ and 45% in UBCS), and about a third had discordant secretor status with their mothers. Non-secretor infants receiving secretor milk in SPATZ showed a significant increase in BMI between week 4/5 and month 3/4 compared to secretor infants. But these associations were not significant after adjusting for confounders and correcting for multiple testing (α threshold = 0.0035). Despite the non-significant results, the findings emphasize the need for further research on discordant secretor status and its health implications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.